UB6-13037-12783 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-14
Registered in v-safe
2021-01-14
Dose 1 — Pfizer-BioNTech
2021-01-14
Health check-in — day 0, dose 1
Feeling: Good · None

Adult check-in
2021-01-15
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-16
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-17
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-02-04
Dose 2 — Pfizer-BioNTech
2021-08-05
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-02-04
Survey response — 12 months, dose 2
MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Be unable to do your normal daily activities

Free text: Reaction to booster sore and enlarged lymph nodes

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-14	Pfizer-BioNTech
2	2021-02-04	Pfizer-BioNTech

Free text

Release 11 — 12 months, dose 2

2022-02-04

Symptoms: Reaction to booster sore and enlarged lymph nodes

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Lymph node pain	·	·	✓
SD	Lymphadenopathy	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release